Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1205 FluvoxamineTarget: Serotonin reuptakeSummary: Selective serotonin reuptake inhibitor
- B1206 PizotifenTarget: 5-HT2 ReceptorsSummary: Highly selective 5-HT receptor blocking agent
- B2007 Pizotifen MalateTarget: 5-HT2 Receptors|D2 ReceptorsSummary: 5-HT receptor antagonist
- B2251 NaratriptanTarget: 5-HT1 ReceptorSummary: selective 5-HT1 receptor subtype agonist
- B2231 Amitriptyline HClTarget: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT TransportersSummary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
- B2236 DesvenlafaxineTarget: 5-HT Transporters|Norepinephrine transportersSummary: serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor
- B2241 OndansetronTarget: 5-HT3 ReceptorsSummary: serotonin 5-HT3 receptor antagonist
- B2248 KetanserinTarget: 5-HT2 ReceptorsSummary: specific 5-HT2A serotonin receptor antagonist
- B6337 8-Hydroxy-DPAT hydrobromideTarget: 5-HT1 ReceptorsSummary: 5-HT1A agonist
- A3317 Clozapine N-oxide (CNO)1 CitationTarget: DREADD LigandsSummary: Metabolite of clozapine, used in chemogenetics.